Fabian Prospective Assessment of Volume Guarantee (Fabian PaVoG)

NCT ID: NCT05229172

Last Updated: 2023-06-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

76 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-02-24

Study Completion Date

2023-06-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is planned as a part of the post market clinical follow-up (PMCF) on a CE marked product and will provide performance data on the Volume Guarantee function of the fabian ventilator in daily clinical routine.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

PaVoG study is a prospective, multicenter, single-cohort post market observational study.

The study procedures will be conducted according to standard of care of each participating hospital and the instructions for use of the study device.

To allow data collection, an Informed Consent Form will be obtained from each study participant/ legally authorized representative, if required by the local Ethical Committee. Ventilator data will be recorded in the hospital's data capture system or on a study laptop provided by the Sponsor.

Each patient will be clinically evaluated according to hospital standard of care. If inclusion and exclusion criteria are met, and the investigative team is available the patient will be enrolled.

Study duration for an individual patient will differ, depending on the time spent on fabian ventilator with Volume Guarantee mode on.

It is anticipated that for most will be between 2-4 days.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Respiratory Insufficiency in Children

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Volume Targeted Ventilation

There is no study specific intervention planned. Procedures will be conducted according to standard of care of each participating hospital and the instructions for use of the study device.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient ventilated with fabian ventilator (conventional or HFOV) with VG mode active.
* The anticipated use of VG mode is at least 12 hours
* Informed Consent given by parents or guardians according to the process approved by the local research ethical committee

Exclusion Criteria

* Patients with severe airflow obstruction and intracranial hypertension
* Decision documented to give palliative neonatal care.
* The clinical care team does not agree with inclusion of the infant to the study
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Vyaire Medical

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gusztav Belteki, MD, PhD

Role: STUDY_CHAIR

Cambridge University Hospitals NHS Trust

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Medical Center Amsterdam, The Netherlands

Amsterdam, , Netherlands

Site Status

Szpital Położniczo - Ginekologiczny Ujastek

Krakow, , Poland

Site Status

Ginekologiczno-Położniczy Szpital Kliniczny Uniwersytetu Medycznego im. Karola Marcinkowskiego

Poznan, , Poland

Site Status

Centre of Postgraduate Medical Education, SPSK im prof.W.Orłowskiego

Warsaw, , Poland

Site Status

John Radcliffe Hospital

Oxford, Oxfordshire, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Netherlands Poland United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CS-21-003-PaVoG

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

CT for Personalized Mechanical Ventilation
NCT05977153 ACTIVE_NOT_RECRUITING NA